BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38108361)

  • 1. The West of Scotland Cohort of Mitochondrial Individuals with the m.3243A>G Variant: Variations in Phenotypes and Predictors of Disease Severity.
    Saunders C; Longman C; Gorman G; James K; Oliwa A; Petty R; Snadden L; Farrugia ME
    J Neuromuscul Dis; 2024; 11(1):179-189. PubMed ID: 38108361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease.
    Grady JP; Pickett SJ; Ng YS; Alston CL; Blakely EL; Hardy SA; Feeney CL; Bright AA; Schaefer AM; Gorman GS; McNally RJ; Taylor RW; Turnbull DM; McFarland R
    EMBO Mol Med; 2018 Jun; 10(6):. PubMed ID: 29735722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De Novo Mutation of m.3243A>G together with m.16093T>C Associated with Atypical Clinical Features in a Pedigree with MIDD Syndrome.
    Jiang Z; Zhang Y; Yan J; Li F; Geng X; Lu H; Wei X; Feng Y; Wang C; Jia W
    J Diabetes Res; 2019; 2019():5184647. PubMed ID: 31143779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial DNA mutation m.3243A>G is associated with altered mitochondrial function in peripheral blood mononuclear cells, with heteroplasmy levels and with clinical phenotypes.
    Geng X; Zhang Y; Yan J; Chu C; Gao F; Jiang Z; Zhang X; Chen Y; Wei X; Feng Y; Lu H; Wang C; Zeng F; Jia W
    Diabet Med; 2019 Jun; 36(6):776-783. PubMed ID: 30536471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-patient variability of heteroplasmy levels in urinary epithelial cells in carriers of the m.3243A>G mutation.
    de Laat P; Rodenburg RJ; Smeitink JAM; Janssen MCH
    Mol Genet Genomic Med; 2019 Feb; 7(2):e00523. PubMed ID: 30516030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical variability of maternally inherited diabetes and deafness is associated with the degree of heteroplasmy in blood leukocytes.
    Laloi-Michelin M; Meas T; Ambonville C; Bellanné-Chantelot C; Beaufils S; Massin P; Vialettes B; Gin H; Timsit J; Bauduceau B; Bernard L; Bertin E; Blickle JF; Cahen-Varsaux J; Cailleba A; Casanova S; Cathebras P; Charpentier G; Chedin P; Crea T; Delemer B; Dubois-Laforgue D; Duchemin F; Ducluzeau PH; Bouhanick B; Dusselier L; Gabreau T; Grimaldi A; Guerci B; Jacquin V; Kaloustian E; Larger E; Lecleire-Collet A; Lorenzini F; Louis J; Mausset J; Murat A; Nadler-Fluteau S; Olivier F; Paquis-Flucklinger V; Paris-Bockel D; Raynaud I; Reznik Y; Riveline JP; Schneebeli S; Sonnet E; Sola-Gazagnes A; Thomas JL; Trabulsi B; Virally M; Guillausseau PJ;
    J Clin Endocrinol Metab; 2009 Aug; 94(8):3025-30. PubMed ID: 19470619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mitochondrial DNA heteroplasmy of the m.3243A>G mutation in maternally inherited diabetes and deafness].
    Cataldo LR; Olmos P; Valerie Smalley S; Díez A; Parada A; Gejman R; Fadic R; Santos JL
    Rev Med Chil; 2013 Mar; 141(3):305-12. PubMed ID: 23900320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining Mitochondrial 3243A>G Heteroplasmy Using an ARMS-ddPCR Strategy.
    Xu P; Jia M; Yan J; Yuan X; Yu W; Zhou Z; Fang H; Gao F; Shen L
    Am J Clin Pathol; 2022 May; 157(5):664-677. PubMed ID: 34698344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATF5, a putative therapeutic target for the mitochondrial DNA 3243A > G mutation-related disease.
    Gao X; Jiang Z; Yan X; Liu J; Li F; Liu P; Li J; Wei Y; Sun YE; Zhang Y; Wang C
    Cell Death Dis; 2021 Jul; 12(7):701. PubMed ID: 34262025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetrance and expressivity of mitochondrial variants in a large clinically unselected population.
    Cannon SJ; Hall T; Hawkes G; Colclough K; Boggan RM; Wright CF; Pickett SJ; Hattersley AT; Weedon MN; Patel KA
    Hum Mol Genet; 2024 Feb; 33(5):465-474. PubMed ID: 37988592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characteristics of Diabetes in People with Mitochondrial DNA 3243A>G Mutation in Korea.
    Rho EH; Baek SI; Lee H; Seong MW; Chae JH; Park KS; Kwak SH
    Diabetes Metab J; 2024 May; 48(3):482-486. PubMed ID: 38311059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic Heterogeneity in 5 Family Members with the Mitochondrial Variant m.3243A>G.
    Finsterer J; Laccone F
    Am J Case Rep; 2020 Nov; 21():e927938. PubMed ID: 33237887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Peripheral Blood Heteroplasmy of the mt.3243A>G Mutation Is Associated with Earlier End-Stage Kidney Disease: A Case Report and Review of the Literature.
    Shand JAD; Potter HC; Pilmore HL; Cundy T; Murphy R
    Nephron; 2020; 144(7):358-362. PubMed ID: 32434190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and progression of diabetes in mitochondrial disease.
    Whittaker RG; Schaefer AM; McFarland R; Taylor RW; Walker M; Turnbull DM
    Diabetologia; 2007 Oct; 50(10):2085-9. PubMed ID: 17653689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The non-syndromic clinical spectrums of mtDNA 3243A>G mutation.
    Shen X; Du A
    Neurosciences (Riyadh); 2021 Apr; 26(2):128-133. PubMed ID: 33814365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and heteroplasmy in blood, urine and saliva in 34 Dutch families carrying the m.3243A > G mutation.
    de Laat P; Koene S; van den Heuvel LP; Rodenburg RJ; Janssen MC; Smeitink JA
    J Inherit Metab Dis; 2012 Nov; 35(6):1059-69. PubMed ID: 22403016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifestyle Changes Normalize Serum Lactate Levels in an m.3243A>G Carrier.
    Finsterer J
    Am J Case Rep; 2021 Apr; 22():e930175. PubMed ID: 33867519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal manifestations in adults with mitochondrial disease from the mtDNA m.3243A>G pathogenic variant.
    Ferreira F; Gonçalves Bacelar C; Lisboa-Gonçalves P; Paulo N; Quental R; Nunes AT; Silva R; Tavares I
    Nefrologia (Engl Ed); 2023 Dec; 43 Suppl 2():1-7. PubMed ID: 38355238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One mutation, three phenotypes: novel metabolic insights on MELAS, MIDD and myopathy caused by the m.3243A > G mutation.
    Esterhuizen K; Lindeque JZ; Mason S; van der Westhuizen FH; Rodenburg RJ; de Laat P; Smeitink JAM; Janssen MCH; Louw R
    Metabolomics; 2021 Jan; 17(1):10. PubMed ID: 33438095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mitochondrial tRNA MT-TW m.5537_5538insT variant presents with significant intra-familial clinical variability.
    Strasser L; Doja A; Davila J; Chakraborty P; Bourque DK
    Am J Med Genet A; 2023 Dec; 191(12):2890-2897. PubMed ID: 37654102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.